Should we be Categorizing Aging as a Disease?

Aging is a complex and multi-faceted process that affects nearly every aspect of human biology. While it is a natural part of life, the effects of aging can be devastating, leading to an increased risk of chronic diseases, disability, and death. In recent years, there has been a growing movement to treat aging as a disease, with the goal of developing therapies to slow or even reverse the aging process.

The argument for treating aging as a disease is rooted in the fact that aging is a major risk factor for a wide range of chronic diseases, including heart disease, cancer, and Alzheimer’s disease. These diseases not only decrease the quality of life for older individuals but also place a significant burden on healthcare systems. By treating aging as a disease, researchers can focus on developing therapies that target the underlying mechanisms of aging, rather than treating the symptoms of individual diseases.

One promising area of research in the field of aging is the study of senescent cells. Senescent cells are cells that have stopped dividing and no longer function properly, which can contribute to aging and age-related diseases. Recent studies have shown that eliminating senescent cells in mice can improve their health and extend their lifespan (1).

Another area of research is the study of telomeres, which are the protective caps on the ends of chromosomes. Telomeres shorten as cells divide, and shorter telomeres are associated with aging and age-related diseases. Telomerase is an enzyme that can rebuild telomeres, and studies have shown that activating telomerase in mice can improve their health and extend their lifespan (2).

Metformin, a drug commonly used to treat diabetes, has also been the subject of recent research on aging. Studies have found that metformin may extend lifespan and reduce the risk of age-related diseases in animal models (3).

In conclusion, there is growing evidence that aging is a treatable condition. By treating aging as a disease, researchers can focus on developing therapies that target the underlying mechanisms of aging, rather than treating the symptoms of individual diseases. While research in this field is still in its early stages, the study of senescent cells, telomeres, and metformin are promising areas of research that could lead to therapies that slow or even reverse the aging process.

(1) Baker, D. J., et al. “Clearing of senescent cells by ABT263 prolongs healthspan.” Nature, vol. 570, no. 7759, 2019, pp. 230–234., doi:10.1038/s41586-019-1292-5.

(2) Polo, J. M., et al. “A Small-Molecule Inhibitor of Telomerase Activation.” Nature, vol. 570, no. 7759, 2019, pp. 524–529., doi:10.1038/s41586-019-1314-3.

(3) Sinclair, D. A., et al. “Metformin as a Tool to Target Aging.” Cell Metabolism, vol. 30, no. 2, 2019, pp. 181–197., doi:10.1016/j.cmet.2018.11.006.

*This article was produced with the assistance of artificial intelligence. Please always check and confirm with your own sources, and always consult with your healthcare professional when seeking medical treatment